人乳头瘤病毒感染的局部免疫反应

本文应用ABC法对30例尖锐湿疣(CA)和30例宫颈癌(CCU)进行原位观察,分析对比两者浸润单一核细胞(MNC)的亚群组成、分布及活化状态。结果提示,两者局部免疫均受抑制,而以宫颈癌为甚。依此本文对不同类型HPV相关疾病的局部免疫反应状态及宿主对不同型别HPV感染的免疫反应进行探讨。     

SIX2在骨肉瘤组织中表达及其对细胞血管生成与阿霉素耐药逆转的影响

探究SIX2在骨肉瘤组织中表达及其对细胞血管生成与阿霉素耐药逆转的影响。方法 收集2019年3月—2021年12月我院行骨肉瘤手术切除的105例患者的组织标本,免疫组化检测骨肉瘤组织中SIX2表达和微血管密度（MVD）计数;检测骨肉瘤组织中SIX2 mRNA表达水平。将人骨肉瘤细胞系MG-63分为MG-63组、si-NC A组、si-SIX2 A组,将通过阿霉素耐药得到的骨肉瘤阿霉素耐药细胞株MG-63/R分为MG-63/R组、si-NC B组和si-SIX2 B组。分别用MTT法、克隆实验、流式细胞术及Transwell法检测细胞耐药性、细胞增殖、细胞凋亡和细胞侵袭。结果 在骨肉瘤组织中,SIX2阳性表达会随着MVD值升高而增加（P＜0.05）。骨肉瘤组织中SIX2阳性表达与TNM分期、软组织浸润和淋巴结远处转移相关（P＞0.05）。与MG-63组相比,si-SIX A组细胞的血管形成能力明显降低（P＜0.05）;与MG-63/R组相比,si-SIX2 B组细胞IC50、细胞克隆数和细胞侵袭能力均显著降低,细胞凋亡能力明显增加,细胞耐药指数逆转倍数为2.51倍（P＜0.05）。结论 SIX2在骨肉瘤组织中呈高表达,且随着SIX2表达的升高肿瘤血管生成能力也增加;抑制SIX2表达可有效抑制骨肉瘤组织的生成,逆转骨肉瘤细胞阿霉素耐药     

Mononuclear-cell subsets in human idiopathic crescentic glomerulonephritis (ICGN): Analysis in tissue sections with monoclonal antibodies

Mononuclear inflammatory cells (MIC) were analyzed in renal biopsies from 16 patients with ICGN (7 with glomerular immune complex deposits, 3 with anti-GBM disease, and 6 without immune deposits) by the avidin-biotin-immunoperoxidase technique utilizing monoclonal antibodies to cell surface antigens: T11 (total T), T4 (inducer/helper T), T8 (suppressor/cytotoxic T), B1 (B cells), M1 (monocytes/granulocytes), and Leu 7 [natural killer (NK) cells]. Total MIC were significantly increased in both glomeruli and interstitial tissues of the patients. Interstitial MIC consisted mainly of lymphocytes (80%) and monocytes (19%), with small numbers of B and NK cells present. In contrast, MIC in renal glomeruli of patients with ICGN were composed of monocytes (65%) rather than T lymphocytes (34%). A majority of T lymphocytes found in renal tissues of patients and controls had the helper/inducer phenotype. Tissue T4/T8 ratios were not significantly different in the glomeruli and interstitium. Monocytes and T lymphocytes accumulating in renal tissues of patients with ICGN may mediate glomerular injury in all forms of human ICGN.Presented in part at the 15th Annual Meeting of the American Society of Nephrology, Chicago, Illinois, 1982.     

Hepatocellular lymphoepithelioma-like carcinoma associated with epstein barr virus: a hitherto unrecognized entity.

OBJECTIVE: Lymphoepithelioma-like carcinoma (LELC) is an undifferentiated carcinoma with a dense lymphoid stroma. It has been reported in diverse organs and shows variable association with Epstein-Barr virus (EBV). Only a few EBV positive cases have been observed in the hepatobiliary system, all of which were considered to be cholangiocarcinomas. We report a unique case of hepatocellular LELC arising in a cirrhotic liver with EBV demonstrated in the tumor cells. METHODS AND RESULTS: A 39-year-old Hispanic female underwent an orthotopic liver transplant for end stage liver disease secondary to chronic hepatitis C. A high-grade hepatocellular carcinoma with a dense lymphocytic infiltrate was found in the explant as well as in a portal lymph node. Three months posttransplant, the patient developed numerous hepatic nodules with enlarged periaortic and portacaval lymph nodes. Biopsy of the hepatic nodules showed a recurrent hepatocellular carcinoma devoid of a dense lymphocytic infiltrate. Both the primary and recurrent tumors were positive for EBV by molecular studies. The patient eventually expired from liver failure over a 6-week period. CONCLUSION: This case represents the first report of EBV-positive hepatocellular LELC. It is particularly interesting given the precipitous clinical outcome, which was possibly related to immunosuppresive therapy.     

pcDNA3.1/hIL-18真核表达载体的构建及表达

目的 :构建重组真核表达质粒pcDNA3.1/IL 18,并在哺乳动物细胞COS 7和Rlc310中进行瞬时和稳定性表达。方法 :从含hIL 18基因的中介载体 pGEM TEasy( pGEM T/hIL 18)中 ,以限制性内切酶酶切方法获得目的片段 ,克隆入真核表达质粒 pcDNA3.1( )中。以脂质体法转染COS 7和Rlc310细胞 ,用RT PCR检测IL 18mRNA的水平 ,免疫组化染色法检测蛋白表达。结果 :构建了hIL 18基因的重组真核表达质粒pcDNA3.1/IL 18,并可在哺乳动物细胞中瞬时、稳定表达 ,获得了可稳定表达hIL 18基因的Rlc310细胞株。结论 :pcDNA3.1/IL 18的构建及表达 ,为IL 18抗肿瘤作用的研究奠定了基础     

CVB3-VP1基因免疫诱导特异性抗病毒免疫应答及保护作用

目的 :构建表达柯萨奇病毒B3(CVB3)主要包膜蛋白VP1的基因疫苗 ,并研究该疫苗诱导CVB3特异性免疫应答及免疫保护的作用。方法 :抽提CVB3RNA ,以RT PCR扩增VP1基因 ,克隆于真核表达载体 pcDNA3中 ,构建质粒pcDNA3 VP1。将该质粒转染Hela细胞 ,观察其表达情况 ;以 5 0 μgpcDNA3 VP1质粒DNA肌注免疫BALB/c小鼠 3次 ,检测CVB3特异性体液和细胞免疫应答。间隔 4wk以 5×LD50 的CVB3攻击小鼠 ,观察攻击后小鼠的存活情况。结果 :构建了重组质粒 pcDNA3 VP1,并在体外获得有效表达。以该质粒肌肉免疫BALB/c小鼠 ,可诱生高水平的IgM和IgG ,VP1多肽特异性淋巴细胞增殖反应及CTL活性均显著高于 pcDNA3免疫的对照组。病毒攻击试验表明 ,pcDNA3 VP1免疫组33.3%小鼠可长期存活 ,其心肌组织未见明显的病理学改变 ;而对照小鼠平均仅存活 6 .7d ,心肌显示大量的局灶性坏死和炎性细胞浸润。结论 :pcDNA3 VP1免疫可诱生CVB3特异性体液及细胞免疫应答 ,保护免疫小鼠抵抗CVB3的致死性攻击     

人胎儿睾丸发生过程中表皮生长因子与细胞增殖核抗原的表达

目的　观察表皮生长因子 (EGF)与细胞增殖核抗原 (PCNA)在人胎儿睾丸发生过程中的表达特征 ,探讨两者在睾丸发生中的作用。　方法　用SP免疫细胞化学技术检测了人胎儿 12～ 32周睾丸间质细胞、支持细胞、生殖细胞EGF、PCNA阳性细胞表达率。　结果　EGF在胎儿 12周龄睾丸组织未见表达 ,16～ 32周龄睾丸间质细胞呈阳性表达 ,16～ 2 0周为表达高峰 ,随着胎龄的增长呈逐渐下降趋势 (P <0 0 1) ;PCNA在胎儿睾丸间质细胞、支持细胞和生殖细胞均有不同程度表达 ,16～ 2 0周为表达高峰 ,随着胎龄的增长呈逐渐下降趋势 (P <0 0 1)。　结论　EGF与PCNA在人胎儿睾丸发育过程中有不同程度的表达 ,表明EGF与PCNA在睾丸发育过程中起着一定的作用     

用标记分析法检测我国海南省登革2型病毒抗原性变化

我们试用标记分析法,用3种单克隆抗体(黄病毒科特异性、登革病毒属特异性和登革病毒2型型特异性单克隆抗体)研究了我国海南省1985～1987年3年内流行的登革2型病毒8个流行株的抗原性变化,并与标准株新几内亚B株进行了比较。发现6株与标准株类似,2株显示出明显的差异。标记分析法为病毒抗原分析提供了一个简便、快速的方法,可用来监测一个地区病毒株群的变化及新株的传入。